Enclomiphene on ExcelMale.com: Dosing & Member Insights

[Nelson Vergel]

Standard Dosing Ranges Discussed by Members​

The three commonly referenced doses on the forum are 6.25 mg, 12.5 mg, and 25 mg. The 12.5 mg/day dose is generally considered standard — one member reported moving from a baseline of 308 ng/dL to 706 ng/dL after one month at 12.5 mg, and to 1,100 ng/dL after three months, with LH rising above 20.

Some members experiment with lower divided doses — e.g., 12.5 mg twice a week (Sunday morning + Wednesday evening) — for milder gonadotropin stimulation, particularly in men with normal-range total T but low Free T and high SHBG who have not previously been on TRT.

Others have found that 12.5 mg every other day (EOD) performed better than 25 mg/day, with the higher daily dose causing accumulation-related side effects including insomnia and skin irritation.

Member-Reported Outcomes​

Hormonal response is often fast:
One member on 12.5 mg/day reported T rising from ~300 to 780 ng/dL in under a month. However, none of the sexual symptoms (libido, erection quality, sensitivity, nocturnal erections) improved over six months on enclomiphene.

Non-responders exist:
One member who started at 12.5 mg/day from Empower Pharmacy saw zero change in Total T (443 ng/dL), Free T, bioavailable T, E2, FSH, or LH after 27 days. The community debated whether to extend the trial, double to 25 mg/day, or consider non-response.

IGF-1 reduction is a notable effect:
Enclomiphene appears to reduce IGF-1 — the clinical trial showed a nearly 50% reduction. Members have individually observed 10–20% decreases, prompting some to combine it with ibutamoren (MK-677) to offset this.

Nelson Vergel's Commentary​

Nelson has directly counseled members that enclomiphene reliably improves numbers on paper — testosterone and fertility markers — but that symptomatic improvement in sexual function is rare. His recommendation for men not responding symptomatically was to transition to TRT (50 mg Test Cypionate twice/week), noting the FDA had also moved against compounded enclomiphene.

Mechanism & Caveats​

Enclomiphene is a Selective Estrogen Receptor Modulator (SERM) that blocks estrogen receptors at the pituitary/hypothalamus level, raising LH and FSH, which instructs the testes to produce more testosterone. The open question is what other receptor populations it blocks and what the long-term effects of chronically elevated LH/FSH might be.

For enclomiphene to work at all, the hypothalamus, pituitary, and testicular Leydig cells must all be functional — if any component is impaired, response is unlikely. Some members anecdotally respond better to clomiphene citrate for unclear reasons.

Recent Regulatory Note​

Members have reported receiving communication from Empower Pharmacy that the FDA was cracking down on compounded enclomiphene — consistent with the broader regulatory environment being tracked in this space.

Bottom-Line Forum Consensus​

Dose	Context
6.25 mg/day	Conservative start or maintenance
12.5 mg/day	Most common starting dose
12.5 mg EOD	Preferred by some to reduce side effects vs. daily 25 mg
25 mg/day	Higher end; risk of insomnia and skin irritation from accumulation
12.5 mg 2×/week	Experimental for mild SHBG/Free T issues

Lab timing: most members retest at 4–6 weeks to assess hormonal response. The forum strongly emphasizes that symptomatic improvement does not always follow lab improvement, which is a consistent theme across dozens of threads.

 

[Nelson Vergel]

Enclomiphene + hCG: ExcelMale Forum Summary​

Primary Use Case: Post-TRT Fertility Recovery​

Combining enclomiphene and hCG is most commonly used when trying to improve sperm count after a period of testosterone replacement therapy. A 2018 BJU International study (Habous et al.) found that men taking enclomiphene alone, hCG alone, and the combination of the two were all equally effective at restoring testosterone in hypogonadism — with no clear advantage for the combination over either monotherapy.

The Pharmacological Conflict: hCG Suppresses LH​

The core theoretical problem with the combination is that hCG will ultimately suppress the body's own LH production through negative feedback. Enclomiphene works by tricking the hypothalamus into releasing more GnRH, which drives the pituitary to produce LH and FSH. However, hCG acts as exogenous LH — and the pituitary, perceiving high LH-equivalent levels from the hCG, will reduce its own LH output in response, potentially negating enclomiphene's central mechanism.

This was confirmed by real member lab data: one member reported that on enclomiphene monotherapy at 12.5 mg/day his LH reached 20.8 mIU/mL. When he switched to enclomiphene 12.5 mg combined with hCG 300 IU on Monday/Wednesday/Friday/Saturday, his LH dropped to 2.7 mIU/mL — demonstrating measurable LH suppression from the hCG component. After returning to enclomiphene monotherapy at 12.5 mg on Monday/Friday/Saturday, his LH recovered to 9.3 mIU/mL.

Real-World Combination Protocols Reported​

One 41-year-old member who had been on TRT for 8+ years used the following protocol prescribed by a fertility specialist for post-TRT recovery:

• hCG 3,000 IU three times per week + Enclomiphene 25 mg daily

Results included a return to baseline testosterone (321 ng/dL), normalized LH and FSH, and testicular rebound in size — but zero sex drive, absent morning erections, and a first sperm sample showing zero counts across the board.

A second member coming off TRT to conceive used:

• Enclomiphene 25 mg/day
• hCG 500 IU EOD
• Anastrozole 0.5 mg EOD

He developed new-onset ED despite total T around 550, free T ~110, and E2 ultrasensitive at 12 — even with 20 mg tadalafil on board.

The AI Problem on This Combination​

Forum members strongly suspected the aromatase inhibitor (anastrozole) as the primary cause of ED in the above case — pointing to an E2 of 12 as likely too suppressed. Notably, enclomiphene itself blocks E2 receptors in the brain, which can mimic symptoms of high E2 including libido loss and ED. The community recommendation was to reduce to enclomiphene 25 mg EOD plus hCG 300 IU EOD while cutting the anastrozole dramatically.

The consensus across multiple threads: AI use with the enclomiphene + hCG combo is high-risk and frequently cited as the primary driver of sexual dysfunction on this stack.

Is Enclomiphene a Direct hCG Replacement?​

The forum is clear that enclomiphene is not a direct replacement for hCG. The two work at entirely different points in the HPT axis — enclomiphene acts centrally at the hypothalamus/pituitary, while hCG acts peripherally at the Leydig cells. The mechanisms are complementary in theory but antagonistic in terms of LH dynamics.

Summary Comparison​

Parameter	Enclomiphene Alone	hCG Alone	Combination
T restoration	Effective	Effective	Effective (no added benefit per Habous 2018)
LH/FSH	Elevated	Suppressed by hCG	Suppressed (hCG dominates)
Fertility/Sperm	Partial	Partial	Most common post-TRT PCT use
Libido/Sexual Function	Rarely improved	Variable	Frequently poor; ED common
AI Risk	Moderate	Moderate	High — crashes E2

Bottom line: The combination normalizes lab numbers but sexual symptoms often remain unresolved. AI use on top of this stack makes outcomes worse in the majority of reported cases.

Reference: Habous M, et al. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study. BJU Int. 2018;122(5):889-897.